Results 211 to 220 of about 311,988 (356)
Nanoparticle‐based tolerogenic vaccines harness controlled antigen delivery and immunomodulation to establish tolerance in autoimmunity and allergy. This review outlines how nanoparticle design (size, shape, composition, administration route) influences biodistribution and immune‐cell targeting.
Benjamin E. Nachod +3 more
wiley +2 more sources
Gangrenous Digital Ischemia Unmasking HIV Infection in Untreated Systemic Sclerosis. [PDF]
Siavosh P +4 more
europepmc +1 more source
Digital ulcer management in patients with systemic sclerosis
Roberta Gualtierotti +5 more
openalex +1 more source
Semi-Supervised Generative Models for Disease Trajectories: A Case Study on Systemic Sclerosis [PDF]
Cécile Trottet +13 more
openalex +1 more source
Cladribine tablets are approved for relapsing multiple sclerosis, mediating their clinical effect by moderately depleting lymphocytes. In a prospective, monocentric study including 22 patients completing 2 annual cycles of cladribine, B‐ and T‐cell receptor repertoires and relapse activity were assessed at baseline and after 24 months. T‐cell clonality
Tilman Schneider‐Hohendorf +8 more
wiley +1 more source
Atypical lung emphysematous changes in systemic sclerosis. [PDF]
Medeiros AK +4 more
europepmc +1 more source
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study [PDF]
Alvarez, Enrique, Cross, Anne H, et al,
core +2 more sources
No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis [PDF]
M. E. Hettema +5 more
openalex +1 more source
Progressive Systemic Sclerosis
openaire +2 more sources

